Maximus, Inc. $MMS Shares Sold by New Age Alpha Advisors LLC

New Age Alpha Advisors LLC reduced its position in shares of Maximus, Inc. (NYSE:MMS) by 27.2% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 35,994 shares of the health services provider’s stock after selling 13,449 shares during the period. New Age Alpha Advisors LLC owned about 0.07% of Maximus worth $3,107,000 as of its most recent SEC filing.

Other institutional investors have also made changes to their positions in the company. Richardson Financial Services Inc. raised its holdings in Maximus by 29.6% in the fourth quarter. Richardson Financial Services Inc. now owns 451 shares of the health services provider’s stock valued at $39,000 after acquiring an additional 103 shares in the last quarter. Farther Finance Advisors LLC raised its holdings in Maximus by 69.0% in the fourth quarter. Farther Finance Advisors LLC now owns 284 shares of the health services provider’s stock valued at $25,000 after acquiring an additional 116 shares in the last quarter. Arizona State Retirement System raised its holdings in Maximus by 0.9% in the third quarter. Arizona State Retirement System now owns 16,674 shares of the health services provider’s stock valued at $1,524,000 after acquiring an additional 156 shares in the last quarter. GAMMA Investing LLC raised its holdings in Maximus by 13.8% in the fourth quarter. GAMMA Investing LLC now owns 1,522 shares of the health services provider’s stock valued at $131,000 after acquiring an additional 185 shares in the last quarter. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its holdings in Maximus by 0.6% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 34,476 shares of the health services provider’s stock valued at $2,351,000 after acquiring an additional 221 shares in the last quarter. 97.21% of the stock is owned by institutional investors and hedge funds.

Maximus Stock Down 0.3%

MMS stock opened at $61.01 on Wednesday. The company has a debt-to-equity ratio of 0.87, a current ratio of 2.21 and a quick ratio of 2.21. Maximus, Inc. has a 1-year low of $56.92 and a 1-year high of $100.00. The firm has a fifty day moving average price of $65.03 and a two-hundred day moving average price of $77.73. The firm has a market cap of $3.21 billion, a price-to-earnings ratio of 9.13 and a beta of 0.60.

Maximus (NYSE:MMS) last released its earnings results on Thursday, May 7th. The health services provider reported $2.07 earnings per share for the quarter, beating the consensus estimate of $1.98 by $0.09. Maximus had a net margin of 7.02% and a return on equity of 25.10%. The firm had revenue of $1.31 billion during the quarter, compared to analyst estimates of $1.32 billion. During the same quarter in the previous year, the firm earned $2.01 earnings per share. The firm’s revenue for the quarter was down 4.1% compared to the same quarter last year. Maximus has set its FY 2026 guidance at 8.250-8.550 EPS. Research analysts predict that Maximus, Inc. will post 8.4 EPS for the current year.

Maximus Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Monday, June 1st. Shareholders of record on Friday, May 15th will be paid a dividend of $0.33 per share. The ex-dividend date is Friday, May 15th. This represents a $1.32 annualized dividend and a yield of 2.2%. Maximus’s payout ratio is presently 19.76%.

Insiders Place Their Bets

In other Maximus news, Director Jan Madsen sold 742 shares of the business’s stock in a transaction on Tuesday, March 17th. The shares were sold at an average price of $72.25, for a total transaction of $53,609.50. Following the completion of the sale, the director owned 20,795 shares in the company, valued at $1,502,438.75. The trade was a 3.45% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 1.80% of the stock is currently owned by insiders.

Wall Street Analyst Weigh In

Several research firms recently issued reports on MMS. Zacks Research cut shares of Maximus from a “strong-buy” rating to a “hold” rating in a report on Monday, April 27th. Weiss Ratings cut shares of Maximus from a “hold (c)” rating to a “hold (c-)” rating in a report on Wednesday, May 20th. Finally, Wall Street Zen cut shares of Maximus from a “buy” rating to a “hold” rating in a report on Monday, February 23rd. Two investment analysts have rated the stock with a Hold rating, Based on data from MarketBeat.com, Maximus currently has an average rating of “Hold”.

Maximus Company Profile

Maximus, Inc (NYSE: MMS) is a global provider of government services focused on delivering health and human services programs. The company partners with federal, state, and local agencies to administer and manage programs that support individuals and families across various stages of life. Key service areas include eligibility determination and enrollment services for Medicaid, Medicare, Children’s Health Insurance Program (CHIP) and other public assistance programs, as well as call center operations, case management and program integrity solutions.